The short version
21 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Avaclyr
Acyclovir · ACYCLOVIR 30 mg/g · Ointment · Ophthalmic · Fera Pharmaceuticals, LLC
NDC 48102-0028-35 · 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for acyclovir (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $18.39 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA202408
- TE code
- —
- Approval date
- Mar 29, 2019
- Patents / exclusivity
- 0 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | ODE-235 | Mar 29, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Acyclovir (Ointment)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Actavis Pharma, Inc. | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Aryeh Pharma Corp | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Bausch Health US, LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Fera Pharmaceuticals, LLC | ACYCLOVIR 30 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Sportpharm LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Viona Pharmaceuticals Inc | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Xiromed, LLC | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | ACYCLOVIR 50 mg/g | Jul 15, 2026 | Aug 28, 2026 |
| c | ACYCLOVIR 50 mg/g | Aug 14, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Avaclyr — NDC 48102-0028-35," retrieved September 3, 2026, https://drugdashboards.com/drug/48102002835.
Free to cite with attribution — see how the data is put together.